Vaccine hesitancy is widely recognized as one of the most significant public health problems of the 21 st Century. The World Health Organization (WHO) identifies vaccine hesitancy ...
In this video interview, Marc Buyse, ScD, founder and CEO of IDDI, makes the case for generalized pairwise comparisons and ...
In this video interview, David Morton, PhD, director of biostatistics at Certara, reflects on the growing role of Bayesian ...
In today’s ACT Brief, we highlight how Bayesian methods are reshaping adaptive trial design, a major eSource partnership is ...
In this video interview, David Morton, PhD, director of biostatistics at Certara, explains how regulatory momentum is ...
Closing the gender gap in data science and tech requires tackling barriers at every stage, from early education through career advancement, while actively challenging the unconscious biases that ...
That's the purpose of the estimand framework—to define ahead of time, before you even start randomizing patients, everything ...
The Patient Advocate Foundation and the PAN Foundation have announced a strategic merger to create the nation’s most ...
An in-depth thought leadership whitepaper explaining how sponsors can operationalize the FDA’s 2025 guidance on inclusive and representative clinical trial design. It outlines current industry ...
In today’s ACT Brief, we examine how the Verana Health-COTA merger is evolving real-world data use, the FDA’s new framework ...
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical ...
This article explores how adopting a “workflow” mindset anchored in measurable sponsor outcomes meets this challenge, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results